Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:18534756rdf:typepubmed:Citationlld:pubmed
pubmed-article:18534756lifeskim:mentionsumls-concept:C1333547lld:lifeskim
pubmed-article:18534756lifeskim:mentionsumls-concept:C0085151lld:lifeskim
pubmed-article:18534756lifeskim:mentionsumls-concept:C0001721lld:lifeskim
pubmed-article:18534756lifeskim:mentionsumls-concept:C1136031lld:lifeskim
pubmed-article:18534756lifeskim:mentionsumls-concept:C1709694lld:lifeskim
pubmed-article:18534756pubmed:issue3lld:pubmed
pubmed-article:18534756pubmed:dateCreated2008-6-16lld:pubmed
pubmed-article:18534756pubmed:abstractTextIn a previous study, we reported that Alzheimer's disease-associated presenilin-2 interacts with a LIM-domain protein, namely, DRAL/FHL2/SLIM3. In this study, we investigated whether DRAL modifies the metabolism of the amyloid precursor protein (APP). We used small interfering RNA (siRNA) to knockdown DRAL in COS7 and HEK293 cells that stably overexpress APP695. We found that the knockdown was accompanied by a decrease in the amount of secreted alpha-secretase-cleaved APP and the membrane-bound C-terminal fragment C83 and an increase in the amount of secreted beta-amyloid peptide (Abeta) from the cells. We also found that in addition to a disintegrin and metalloprotease (ADAM)-17, DRAL binds to ADAM-10. Thus, DRAL may be involved in the processing of APP through the alpha-secretase pathway.lld:pubmed
pubmed-article:18534756pubmed:languageenglld:pubmed
pubmed-article:18534756pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18534756pubmed:citationSubsetIMlld:pubmed
pubmed-article:18534756pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18534756pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18534756pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18534756pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18534756pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18534756pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18534756pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18534756pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18534756pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18534756pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18534756pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18534756pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18534756pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18534756pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18534756pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18534756pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18534756pubmed:statusMEDLINElld:pubmed
pubmed-article:18534756pubmed:monthJullld:pubmed
pubmed-article:18534756pubmed:issn0304-3940lld:pubmed
pubmed-article:18534756pubmed:authorpubmed-author:TanahashiHiro...lld:pubmed
pubmed-article:18534756pubmed:authorpubmed-author:YoshiokaKatsu...lld:pubmed
pubmed-article:18534756pubmed:issnTypePrintlld:pubmed
pubmed-article:18534756pubmed:day18lld:pubmed
pubmed-article:18534756pubmed:volume439lld:pubmed
pubmed-article:18534756pubmed:ownerNLMlld:pubmed
pubmed-article:18534756pubmed:authorsCompleteYlld:pubmed
pubmed-article:18534756pubmed:pagination293-7lld:pubmed
pubmed-article:18534756pubmed:dateRevised2011-11-17lld:pubmed
pubmed-article:18534756pubmed:meshHeadingpubmed-meshheading:18534756...lld:pubmed
pubmed-article:18534756pubmed:meshHeadingpubmed-meshheading:18534756...lld:pubmed
pubmed-article:18534756pubmed:meshHeadingpubmed-meshheading:18534756...lld:pubmed
pubmed-article:18534756pubmed:meshHeadingpubmed-meshheading:18534756...lld:pubmed
pubmed-article:18534756pubmed:meshHeadingpubmed-meshheading:18534756...lld:pubmed
pubmed-article:18534756pubmed:meshHeadingpubmed-meshheading:18534756...lld:pubmed
pubmed-article:18534756pubmed:meshHeadingpubmed-meshheading:18534756...lld:pubmed
pubmed-article:18534756pubmed:meshHeadingpubmed-meshheading:18534756...lld:pubmed
pubmed-article:18534756pubmed:meshHeadingpubmed-meshheading:18534756...lld:pubmed
pubmed-article:18534756pubmed:meshHeadingpubmed-meshheading:18534756...lld:pubmed
pubmed-article:18534756pubmed:meshHeadingpubmed-meshheading:18534756...lld:pubmed
pubmed-article:18534756pubmed:meshHeadingpubmed-meshheading:18534756...lld:pubmed
pubmed-article:18534756pubmed:meshHeadingpubmed-meshheading:18534756...lld:pubmed
pubmed-article:18534756pubmed:meshHeadingpubmed-meshheading:18534756...lld:pubmed
pubmed-article:18534756pubmed:meshHeadingpubmed-meshheading:18534756...lld:pubmed
pubmed-article:18534756pubmed:meshHeadingpubmed-meshheading:18534756...lld:pubmed
pubmed-article:18534756pubmed:meshHeadingpubmed-meshheading:18534756...lld:pubmed
pubmed-article:18534756pubmed:year2008lld:pubmed
pubmed-article:18534756pubmed:articleTitleRNA interference silencing of DRAL affects processing of amyloid precursor protein.lld:pubmed
pubmed-article:18534756pubmed:affiliationDivision of Molecular Cell Signaling, Cancer Research Institute, Kanazawa University, 13-1 Takaramachi, Kanazawa, Ishikawa 920-0934, Japan. tanahashi_h@ybb.ne.jplld:pubmed
pubmed-article:18534756pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:18534756pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18534756lld:pubmed